Ausgabe 3/2017
Inhalt (7 Artikel)
Binge Drinking: Current Diagnostic and Therapeutic Issues
Benjamin Rolland, Mickaël Naassila
Nogo-A Antibodies for Progressive Multiple Sclerosis
Benjamin V. Ineichen, Patricia S. Plattner, Nicolas Good, Roland Martin, Michael Linnebank, Martin E. Schwab
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
Leonie Hennissen, Mireille J. Bakker, Tobias Banaschewski, Sara Carucci, David Coghill, Marina Danckaerts, Ralf W. Dittmann, Chris Hollis, Hanna Kovshoff, Suzanne McCarthy, Peter Nagy, Edmund Sonuga-Barke, Ian C. K. Wong, Alessandro Zuddas, Eric Rosenthal, Jan K. Buitelaar
Outcome Measures in Clinical Trials for Multiple Sclerosis
Caspar E. P. van Munster, Bernard M. J. Uitdehaag
Impact of Drug Manipulation on Seizure Freedom in Adults with Uncontrolled Epilepsy: A Prospective Controlled Study in Rural China
Xiaoting Hao, Ziyi Chen, Bo Yan, Patrick Kwan, Dong Zhou
Benzodiazepine Use and Risk of Developing Alzheimer’s Disease: A Case-Control Study Based on Swiss Claims Data
Fabienne A. Biétry, Alena M. Pfeil, Oliver Reich, Matthias Schwenkglenks, Christoph R. Meier